Cambridge, Mass.
Biopharmaceutical firm Baxalta is developing a 200,000-sf research and development center in Cambridge, Mass. Located at Kendall Square, the leased facility will support the commercialization of preclinical discoveries made in partnership with academic institutions and independent biotech firms. The project is expected to house approximately 500 employees upon completion in late 2015. Baxalta is a subsidiary of Baxter International, based in Deerfield, Ill.
